Gilead Sciences GILD
NASDAQ GILD
$156.19 -1.18 (-0.75%)
At close: Oct 16, 2026 · 4:00 PM EDT

Gilead Sciences (GILD) Amortizatization of Intangibles (2009 - 2026)

Updated

Gilead Sciences' Amortizatization of Intangibles was $600 million in Q2 2026, up 0.3% from $598 million a year earlier and up 0.7% from the prior quarter.

Analysis

Gilead Sciences (GILD) Amortizatization of Intangibles (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Gilead Sciences' Amortizatization of Intangibles was $2.39 billion through Jun 30, 2026, down 0.1% year-over-year; for FY2025, it came in at $2.39 billion, up 0.2% from FY2024.

  • Amortizatization of Intangibles has now increased for six consecutive years, with a five-year compound annual growth rate of 14.9% (FY2020 to FY2025).
  • In earlier years, Amortizatization of Intangibles was $2.39 billion in FY2024 (+2.0%), $2.34 billion in FY2023 (+31.4%), $1.78 billion in FY2022 (+3.4%) and $1.72 billion in FY2021 (+44.4%).
  • The Q2 2026 figure marks the highest quarterly Amortizatization of Intangibles in data going back to Q1 2009.
  • Compared with a year earlier, Amortizatization of Intangibles was higher in four of the last eight quarters, with an average year-over-year change of 0.0%.
  • The best year-over-year quarter for Amortizatization of Intangibles over five years was Q3 2021 (growth of 56.4%); the worst was Q1 2026 (a decline of 0.5%).
  • Per Business Quant data, GILD's Amortizatization of Intangibles in the three quarters before Q2 2026 was $596 million (Q1 2026), $597 million (Q4 2025) and $596 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amort. of Intangibles (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn -
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn -
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 1.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 984.00 Mn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn -
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn -
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn -
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 600.00 Mn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 600.00 Mn
Mar 31, 2026 596.00 Mn
Dec 31, 2025 597.00 Mn
Sep 30, 2025 596.00 Mn
Jun 30, 2025 598.00 Mn
Mar 31, 2025 599.00 Mn
Dec 31, 2024 598.00 Mn
Sep 30, 2024 596.00 Mn
Jun 30, 2024 596.00 Mn
Mar 31, 2024 596.00 Mn
Dec 31, 2023 597.00 Mn
Sep 30, 2023 598.00 Mn
Jun 30, 2023 598.00 Mn
Mar 31, 2023 546.00 Mn
Dec 31, 2022 445.00 Mn
Sep 30, 2022 445.00 Mn
Jun 30, 2022 445.00 Mn
Mar 31, 2022 445.00 Mn
Dec 31, 2021 445.00 Mn
Sep 30, 2021 441.00 Mn
API Access

Gilead Sciences Amortizatization of Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=GILD&period=max&api_key=YOUR_API_KEY